Kidney Disease Clinical Trials in San Antonio

Showing 141-160 of 284 trials

A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment

NCT05673603

The primary purpose of the study is to determine the pharmacokinetics (PK) following a single oral dose administration of brensocatib, safety, and tolerability of brensocatib when administered to participants with impaired renal function and in healthy participants.

Renal Impairment

Insmed Incorporated28 participantsStarted Jul 2021

Orlando, Florida, United States • Tampa, Florida, United States • San Antonio, Texas, United States

TERMINATEDNA< 1 mile

Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury

NCT04877847

Multi-center randomized trial to assess the safety and performance of low-frequency therapeutic ultrasound for maintaining renal function after contrast exposure.

Contrast-induced NephropathyChronic Kidney Diseases

Sonogenix2 participantsStarted Sep 2021

Detroit, Michigan, United States • Petoskey, Michigan, United States • Pittsburgh, Pennsylvania, United States +1 more locations

COMPLETEDPhase 2< 1 mile

A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia

NCT03990363

The purpose of this clinical research study is to establish the dose of verinurad combined with allopurinol 300 mg once daily that will elicit the desired response; ie, reduction in urinary albumin to creatinine ratio (UACR) at 6 months.

Chronic Kidney Disease

AstraZeneca861 participantsStarted Jul 2019

Huntsville, Alabama, United States • Bakersfield, California, United States • Canyon Country, California, United States +162 more locations

A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment

Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury

A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia

Kidney Disease Trials in Other Cities

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

A Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairment

Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease

Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)

A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)

A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease

A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function

Other Conditions in San Antonio